In a research report released Tuesday, HC Wainwright analyst Reni Benjamin reiterated a Buy rating on CTI BioPharma Corp (CTIC) with a price target of $6.00 following the completion of …
In a research note released today, Janney Capital analyst Kimberly Lee maintained a Buy rating on Cell Therapeutics Inc. (CTIC) with a $4 fair value estimate, …
In a research note issued this morning, H.C.
